Evidence map›Paper›PMID 28925794›Full record

ReviewHuman vaccines & immunotherapeutics2017

Developments in the formulation and delivery of spray dried vaccines.

Gaurav Kanojia, Rimko Ten Have, Peter C Soema, Henderik Frijlink, Jean-Pierre Amorij, Gideon Kersten

Open access · bronzeAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Trends in uptake and impact of thermostable vaccines in Africa.Therapeutic advances in vaccines and immunotherapy · 2025
    Review
  10. Article
  11. Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Review
  12. Review
  13. Spray Drying of Bacterial Membrane Vesicles for Vaccine Delivery.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Gaurav Kanojiaa Intravacc (Institute for Translational Vaccinology) , Bilthoven , The Netherlands.
Rimko Ten Havea Intravacc (Institute for Translational Vaccinology) , Bilthoven , The Netherlands.
Peter C Soemaa Intravacc (Institute for Translational Vaccinology) , Bilthoven , The Netherlands.
Henderik Frijlinkb Department of Pharmaceutical Technology and Biopharmacy , University of Groningen , Groningen , The Netherlands.
Jean-Pierre Amorijd Virtuvax BV , Odijk , The Netherlands.
Gideon Kerstena Intravacc (Institute for Translational Vaccinology) , Bilthoven , The Netherlands.
Intravacc (Netherlands) · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spray drying is a promising method for the stabilization of vaccines, which are usually formulated as liquids. Usually, vaccine stability is improved by spray drying in the presence of a range of excipients. Unlike freeze drying, there is no freezing step involved, thus the damage related to this step is avoided. The edge of spray drying resides in its ability for particles to be engineered to desired requirements, which can be used in various vaccine delivery methods and routes. Although several spray dried vaccines have shown encouraging preclinical results, the number of vaccines that have been tested in clinical trials is limited, indicating a relatively new area of vaccine stabilization and delivery. This article reviews the current status of spray dried vaccine formulations and delivery methods. In particular it discusses the impact of process stresses on vaccine integrity, the application of excipients in spray drying of vaccines, process and formulation optimization strategies based on Design of Experiment approaches as well as opportunities for future application of spray dried vaccine powders for vaccine delivery.

Indexed as

Administration, OralAnimalsChemistry, PharmaceuticalDesiccationDrug CompoundingHumansInfluenza VaccinesMiceNasal SpraysParticle SizePowdersVaccine PotencyVaccinesInfluenza VaccinesNasal SpraysPowdersVaccinesDeliveryDry Powder VaccineFormulation and Design of ExperimentsSpray dryingVaccine

Identifiers

PMID28925794
PMCPMC5647985
OpenAlexW2755270747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.